Skip to content

Clinical study of Cross-Auxiliary liver Transplantation for metabolic liver diseases

Clinical study of Cross-Auxiliary liver Transplantation for metabolic liver diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-15006214
Enrollment
Unknown
Registered
2015-04-08
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic liver disease

Interventions

Case series:cross-auxiliary liver transplantation

Sponsors

Captital Medical University Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) the patients themselves or guardian sign the informed consent; 2) clear liver metabolic diseases, clinical diagnosis and genetic diagnosis; 3) the disease can progress viscera function failure and even death; 4) disease seriously affect the growth and development or the quality of life; 5) disease medical treatment with no clear radical treatment.

Exclusion criteria

Exclusion criteria: 1) cumulative liver disease lead to irreversible pathological morphological changes, such as liver cirrhosis; 2) after strict preoperative evaluation of liver transplantation, liver transplantation surgery contraindications; 3) treatment and an analysis cannot meet the specimen.

Design outcomes

Primary

MeasureTime frame
metabolic index;

Countries

China

Contacts

Public ContactZhi-jun Zhu
fchquwei@hotmail.com+86 18601253456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026